Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a difficult to treat tumor with a poor prognosis. Aspartate β-hydroxylase (ASPH) is a highly conserved enzyme overexpressed on the cell surface of both murine and human HCC cells. METHODS: We evaluated therapeutic effects of nanoparticle lambda...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Heliyon
Autors principals: Iwagami, Yoshifumi, Casulli, Sarah, Nagaoka, Katsuya, Kim, Miran, Carlson, Rolf I., Ogawa, Kosuke, Lebowitz, Michael S., Fuller, Steve, Biswas, Biswajit, Stewart, Solomon, Dong, Xiaoqun, Ghanbari, Hossein, Wands, Jack R.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5619992/
https://ncbi.nlm.nih.gov/pubmed/28971150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2017.e00407
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars